Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04970368 · ClinicalTrials.gov registry record · Phase 3
Comparison of Nodal Staging in Endometrial Cancer
A Phase 3 study, sponsored by Frederick R. Ueland, M.D..
- Terminated
- Registry status
- Phase 3
- Development phase
- 38
- Enrollment target
NCT04970368 is a Phase 3 study that was terminated before completion, run by Frederick R. Ueland, M.D.. The registered enrollment target is 38 participants.
The verdict
NCT04970368, a Phase 3 study, was terminated before completion, sponsored by Frederick R. Ueland, M.D..
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging.
Interventions
- PROCEDURE Sentinel node procedure
- PROCEDURE Selective staging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-11-05 |
| Est. Completion | 2023-06-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04970368
The ClinicalTrials.gov registry entry for NCT04970368 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Frederick R. Ueland, M.D., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sentinel node procedure is the first listed.
NCT04970368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04970368 about?
NCT04970368 is a clinical study titled "Comparison of Nodal Staging in Endometrial Cancer". This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging.
What is the current status of trial NCT04970368?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 38 participants. The study started on 2021-11-05. Estimated completion is 2023-06-13.
What interventions are being tested in trial NCT04970368?
The interventions under investigation include: Sentinel node procedure (PROCEDURE), Selective staging (PROCEDURE).
Who is sponsoring clinical trial NCT04970368?
This trial is sponsored by Frederick R. Ueland, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.